Biocartis Group NV
XBRU:BCART

Watchlist Manager
Biocartis Group NV Logo
Biocartis Group NV
XBRU:BCART
Watchlist
Price: 0.29 EUR Market Closed
Market Cap: 27.2m EUR
Have any thoughts about
Biocartis Group NV?
Write Note

Biocartis Group NV
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Biocartis Group NV
Other Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Biocartis Group NV
XBRU:BCART
Other Current Liabilities
€10.1m
CAGR 3-Years
10%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Nyxoah SA
XBRU:NYXH
Other Current Liabilities
€4.3m
CAGR 3-Years
20%
CAGR 5-Years
74%
CAGR 10-Years
N/A
Ion Beam Applications SA
XBRU:IBAB
Other Current Liabilities
€330.4m
CAGR 3-Years
20%
CAGR 5-Years
21%
CAGR 10-Years
N/A
Sequana Medical NV
XBRU:SEQUA
Other Current Liabilities
€3.2m
CAGR 3-Years
9%
CAGR 5-Years
17%
CAGR 10-Years
N/A
No Stocks Found

Biocartis Group NV
Glance View

Market Cap
27m EUR
Industry
Health Care

Biocartis Group NV which engages in the development of oncology molecular diagnostic solutions. The company is headquartered in Malines (Mechelen), Antwerpen and currently employs 619 full-time employees. The company went IPO on 2015-04-27. The group has the Idylla system to deliver results within a period of between 35 to 150 minutes.

BCART Intrinsic Value
0.94 EUR
Undervaluation 69%
Intrinsic Value
Price

See Also

What is Biocartis Group NV's Other Current Liabilities?
Other Current Liabilities
10.1m EUR

Based on the financial report for Jun 30, 2023, Biocartis Group NV's Other Current Liabilities amounts to 10.1m EUR.

What is Biocartis Group NV's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 5Y
11%

Over the last year, the Other Current Liabilities growth was 1%. The average annual Other Current Liabilities growth rates for Biocartis Group NV have been 10% over the past three years , 11% over the past five years .

Back to Top